Home › Companies › REGENXBIO INC. › 2023-2024

REGENXBIO INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and REGENXBIO INC.’s Form 8-K, filed June 3, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.

5Ballot items
211Asset managers
1,346Fund votes
May 31, 2024Meeting date

Results at a glance

Meeting of May 31, 2024: 5 items on REGENXBIO INC.’s Form 8-K, filed June 3, 2024: 3 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore REGENXBIO INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by REGENXBIO INC.

These tallies are REGENXBIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

REGENXBIO INC. — official shareholder meeting results, meeting held May 31, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: George Migausky	39,124,767	--	--	1,785,552	3,342,209	96%	Elected	—
Elect Director: Kenneth T. Mills	39,258,562	--	--	1,651,757	3,342,209	96%	Elected	—
Elect Director: David C. Stump	35,039,630	--	--	5,870,689	3,342,209	86%	Elected	—
2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024	44,152,900	58,293	41,335	--	0	99.8%	Approved	—
3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement	40,147,111	727,846	35,362	--	3,342,209	98%	Approved	—

Source: REGENXBIO INC., Form 8-K, filed with the SEC on June 3, 2024 — read the filing on EDGAR.

How asset managers voted at the REGENXBIO INC. 2023-2024 meeting

Each item below shows how the 211 asset managers that disclosed a REGENXBIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: David C. Stump

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%WITHHELD

FOR: 35,039,630WITHHELD: 5,870,689

Details: description as filed, official tally, votes by 67 asset managers

Description as filed by funds: Election of Three Class III Directors: David C. Stump, M.D.

REGENXBIO INC.’s own tally for this item (“Elect Director: David C. Stump”): 35,039,630 for, 5,870,689 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class III directors until the Company's 2027 annual meeting of stockholders:”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 15,583,385 for, 2,080,686 withheld, 133,108 abstained, 30,933 not voted.

FOR

FOR: 15,583,385ABSTAIN: 133,108WITHHOLD: 2,080,686NOT VOTED: 30,933

Largest asset managers voting on “Election of Three Class III Directors: David C. Stump, M.D.” at REGENXBIO INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
BlackRock	5,145,306	0	0	For
Vanguard	4,787,421	0	0	For
State Street	2,165,730	0	30,522	For
JPMorgan	1,503,669	0	0	For
Dimensional	0	0	962,879	Withhold
Fidelity	912,152	0	100	For
Charles Schwab	322,699	0	0	For
Columbia Threadneedle	262,020	0	0	For
AIG/SunAmerica	0	0	190,306	Withhold
Delaware/Macquarie	0	0	149,000	Withhold
Equitable	63,127	0	52,900	Mixed
TIAA	0	0	104,839	Withhold
Direxion Shares ETF Trust	0	0	104,095	Withhold
Jackson National	0	102,923	0	Abstain
Global X	91,620	0	0	For
QUANTITATIVE MASTER SERIES LLC	74,435	0	0	For
American Century	0	0	63,823	Withhold
BNY Mellon	0	0	59,339	Withhold
Principal	125	0	46,273	Withhold
Prudential/PGIM	42,218	0	0	For
ProShares	0	0	40,884	Withhold
Lincoln Financial	34,200	0	5,071	Mixed
Thrivent	0	0	35,111	Withhold
Northern Trust	0	0	34,428	Withhold
Brighthouse	0	0	31,303	Withhold

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

2. Elect Director: George Migausky

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 39,124,767WITHHELD: 1,785,552

Details: description as filed, official tally, votes by 67 asset managers

Description as filed by funds: Election of Three Class III Directors: George Migausky

REGENXBIO INC.’s own tally for this item (“Elect Director: George Migausky”): 39,124,767 for, 1,785,552 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class III directors until the Company's 2027 annual meeting of stockholders:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 16,714,664 for, 1,059,719 withheld, 22,796 abstained, 30,933 not voted.

FOR

FOR: 16,714,664ABSTAIN: 22,796WITHHOLD: 1,059,719NOT VOTED: 30,933

Largest asset managers voting on “Election of Three Class III Directors: George Migausky” at REGENXBIO INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
BlackRock	5,145,306	0	0	For
Vanguard	4,787,421	0	0	For
State Street	2,193,365	0	2,887	For
JPMorgan	1,503,669	0	0	For
Dimensional	0	0	962,879	Withhold
Fidelity	912,252	0	0	For
Charles Schwab	322,699	0	0	For
Columbia Threadneedle	262,020	0	0	For
AIG/SunAmerica	190,306	0	0	For
Delaware/Macquarie	149,000	0	0	For
Equitable	63,127	0	52,900	Mixed
TIAA	104,839	0	0	For
Direxion Shares ETF Trust	104,095	0	0	For
Jackson National	89,251	13,672	0	Mixed
Global X	91,620	0	0	For
QUANTITATIVE MASTER SERIES LLC	74,435	0	0	For
American Century	63,823	0	0	For
BNY Mellon	59,339	0	0	For
Principal	46,398	0	0	For
Prudential/PGIM	42,218	0	0	For
ProShares	40,884	0	0	For
Lincoln Financial	34,200	0	5,071	Mixed
Thrivent	35,111	0	0	For
Northern Trust	34,428	0	0	For
Brighthouse	13,066	0	18,237	Mixed

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

3. Elect Director: Kenneth T. Mills

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 39,258,562WITHHELD: 1,651,757

Details: description as filed, official tally, votes by 67 asset managers

Description as filed by funds: Election of Three Class III Directors: Kenneth T. Mills

REGENXBIO INC.’s own tally for this item (“Elect Director: Kenneth T. Mills”): 39,258,562 for, 1,651,757 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class III directors until the Company's 2027 annual meeting of stockholders:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 16,767,564 for, 1,006,819 withheld, 22,796 abstained, 30,933 not voted.

FOR

FOR: 16,767,564ABSTAIN: 22,796WITHHOLD: 1,006,819NOT VOTED: 30,933

Largest asset managers voting on “Election of Three Class III Directors: Kenneth T. Mills” at REGENXBIO INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
BlackRock	5,145,306	0	0	For
Vanguard	4,787,421	0	0	For
State Street	2,193,365	0	2,887	For
JPMorgan	1,503,669	0	0	For
Dimensional	0	0	962,879	Withhold
Fidelity	912,252	0	0	For
Charles Schwab	322,699	0	0	For
Columbia Threadneedle	262,020	0	0	For
AIG/SunAmerica	190,306	0	0	For
Delaware/Macquarie	149,000	0	0	For
Equitable	116,027	0	0	For
TIAA	104,839	0	0	For
Direxion Shares ETF Trust	104,095	0	0	For
Jackson National	89,251	13,672	0	Mixed
Global X	91,620	0	0	For
QUANTITATIVE MASTER SERIES LLC	74,435	0	0	For
American Century	63,823	0	0	For
BNY Mellon	59,339	0	0	For
Principal	46,398	0	0	For
Prudential/PGIM	42,218	0	0	For
ProShares	40,884	0	0	For
Lincoln Financial	34,200	0	5,071	Mixed
Thrivent	35,111	0	0	For
Northern Trust	34,428	0	0	For
Brighthouse	13,066	0	18,237	Mixed

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

4. 3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 40,147,111AGAINST: 727,846

Details: description as filed, official tally, votes by 211 asset managers

Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.

REGENXBIO INC.’s own tally for this item (“3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement”): 40,147,111 for, 727,846 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 : By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 68 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at REGENXBIO INC., 2023-2024
Asset manager	For	Abstain	Vote
BlackRock	5,145,306	0	For
Vanguard	4,787,421	0	For
State Street	2,196,252	0	For
JPMorgan	1,503,669	0	For
Dimensional	962,879	0	For
Fidelity	912,252	0	For
Charles Schwab	322,699	0	For
Columbia Threadneedle	262,020	0	For
AIG/SunAmerica	190,306	0	For
Delaware/Macquarie	149,000	0	For
Equitable	116,027	0	For
TIAA	104,839	0	For
Direxion Shares ETF Trust	104,095	0	For
Jackson National	102,923	0	For
Global X	91,620	0	For
QUANTITATIVE MASTER SERIES LLC	74,435	0	For
American Century	63,823	0	For
BNY Mellon	59,339	0	For
Principal	46,398	0	For
Prudential/PGIM	42,218	0	For
ProShares	40,884	0	For
Lincoln Financial	39,271	0	For
Thrivent	35,111	0	For
Northern Trust	34,428	0	For
Brighthouse	13,066	18,237	Mixed

Fund voting reports, all 68 managers: 17,774,439 for, 6,046 against, 18,237 abstained, 30,933 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 162 asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at REGENXBIO INC., 2023-2024
Asset manager	For	Against	Vote
Redmile Group, LLC	4,551,556	0	For
JPMorgan	3,405,382	0	For
State Street	3,002,984	0	For
BlackRock	1,812,342	1,024	For
Avidity Partners Management LP	1,246,556	0	For
GEODE CAPITAL MANAGEMENT, LLC	950,551	0	For
MPM BioImpact LLC	549,078	0	For
Northern Trust	367,276	855	For
WS MANAGEMENT LLLP	351,918	0	For
Charles Schwab	343,447	0	For
RTW INVESTMENTS, LP	342,418	0	For
Aquilo Capital Management, LLC	308,973	0	For
MELLON INVESTMENTS Corp	286,142	0	For
ArchPoint Investors	221,197	0	For
PRINCIPAL GLOBAL INVESTORS	216,211	0	For
Kintegral Advisory, LLC	201,981	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	177,576	0	For
Dimensional	175,305	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	165,073	0	For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	149,000	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	138,905	0	For
PANAGORA ASSET MANAGEMENT INC	128,686	0	For
BALYASNY ASSET MANAGEMENT L.P.	112,451	0	For
STIFEL NICOLAUS & CO INC \MO\	106,239	0	For
Nuveen	105,768	0	For

Institutional-manager reports, all 162 managers: 21,334,071 for, 371,842 against. Showing the 25 largest; see all in the interactive database.

5. 2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%

FOR: 44,152,900AGAINST: 58,293

Details: description as filed, official tally, votes by 69 asset managers

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2024.

REGENXBIO INC.’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 44,152,900 for, 58,293 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 69 asset managers below reported 17,777,404 for, 3,131 against, 18,237 abstained, 30,933 not voted.

FOR

FOR: 17,777,404AGAINST: 3,131ABSTAIN: 18,237NOT VOTED: 30,933

Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as th” at REGENXBIO INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
BlackRock	5,145,306	0	0	For
Vanguard	4,787,421	0	0	For
State Street	2,193,121	3,131	0	For
JPMorgan	1,503,669	0	0	For
Dimensional	962,879	0	0	For
Fidelity	912,252	0	0	For
Charles Schwab	322,699	0	0	For
Columbia Threadneedle	262,020	0	0	For
AIG/SunAmerica	190,306	0	0	For
Delaware/Macquarie	149,000	0	0	For
Equitable	116,027	0	0	For
TIAA	104,839	0	0	For
Direxion Shares ETF Trust	104,095	0	0	For
Jackson National	102,923	0	0	For
Global X	91,620	0	0	For
QUANTITATIVE MASTER SERIES LLC	74,435	0	0	For
American Century	63,823	0	0	For
BNY Mellon	59,339	0	0	For
Principal	46,398	0	0	For
Prudential/PGIM	42,218	0	0	For
ProShares	40,884	0	0	For
Lincoln Financial	39,271	0	0	For
Thrivent	35,111	0	0	For
Northern Trust	34,428	0	0	For
Brighthouse	13,066	0	18,237	Mixed

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

Largest REGENXBIO INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 49,043,000 shares outstanding at the time of that meeting.

Fund voting reports: top REGENXBIO INC. shareholders by shares voted on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE…”, 2023-2024
#	Asset manager	% of shares outstanding
1	BlackRock	10.49%
2	Vanguard	9.76%
3	State Street	4.48%
4	JPMorgan	3.07%
5	Dimensional	1.96%
6	Fidelity	1.86%
7	Charles Schwab	0.66%
8	Columbia Threadneedle	0.53%
9	AIG/SunAmerica	0.39%
10	Delaware/Macquarie	0.30%

Institutional-manager reports: top REGENXBIO INC. shareholders by shares voted on “TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE…”, 2023-2024
#	Asset manager	% of shares outstanding
1	Redmile Group, LLC	9.28%
2	JPMorgan	6.94%
3	State Street	6.12%
4	BlackRock	3.70%
5	Avidity Partners Management LP	2.54%
6	GEODE CAPITAL MANAGEMENT, LLC	1.94%
7	MPM BioImpact LLC	1.12%
8	Northern Trust	0.75%
9	WS MANAGEMENT LLLP	0.72%
10	Charles Schwab	0.70%

Reported REGENXBIO INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

REGENXBIO INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	12.99%	13F
Redmile Group, LLC	10.10%	DEF14A
JPMorgan Chase	8.23%	13F
Vanguard Group	6.81%	13F
State Street	6.37%	13F
Entities Affiliated with Allan M. Fox Bryn Mawr Trust Company	5.88%	DEF14A
Goldman Sachs	3.78%	13F
Morgan Stanley	3.48%	13F
Dimensional Fund Advisors	2.44%	13F
Geode Capital	1.94%	13F

Percentages above are of 49,043,000 shares outstanding, as reported by REGENXBIO INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENXBIO INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At REGENXBIO INC.'s shareholder meeting held May 31, 2024, in the 2023-2024 proxy season, 211 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,346 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE… — REGENXBIO INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: REGENXBIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2024.

REGENXBIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.